Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun;52(2):137-139.
doi: 10.5045/br.2017.52.2.137. Epub 2017 Jun 22.

Acute megakaryoblastic blast crisis as a presentation manifestation of chronic myelogenous leukemia

Affiliations

Acute megakaryoblastic blast crisis as a presentation manifestation of chronic myelogenous leukemia

Jenna B Bhattacharya et al. Blood Res. 2017 Jun.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Authors' Disclosures of Potential Conflicts of Interest: No potential conflicts of interest relevant to this article were reported.

Figures

Fig. 1
Fig. 1. (A) PCR showing bcr-abl positivity and (B) T315I mutation (L, 100 bp ladder; P1, Positive Control; P2, positive for (A) BCR/ABL or (B) T315).
Fig. 2
Fig. 2. (A) Bone marrow aspiration showing blasts with abundant granular cytoplasm and small vesicular nuclei (Giemsa, ×400). (B) Bone marrow biopsy showed replacement of hematopoietic precursors with blasts with vesicular nuclei and prominent nucleoli (H & E, ×400). (C) Biopsy showed blasts positive for CD61 and (D) positive for CD34.

References

    1. Choi W, Kim M, Lim J, et al. Four cases of chronic myelogenous leukemia in mixed phenotype blast phase at initial presentation mimicking mixed phenotype acute leukemia with t(9;22) Ann Lab Med. 2014;34:60–63. - PMC - PubMed
    1. Pagano L, Pulsoni A, Vignetti M, et al. Acute megakaryoblastic leukemia: experience of GIMEMA trials. Leukemia. 2002;16:1622–1626. - PubMed
    1. Al-Shehri A, Al-Seraihy A, Owaidah TM, Belgaumi AF. Megakaryocytic blast crisis at presentation in a pediatric patient with chronic myeloid leukemia. Hematol Oncol Stem Cell Ther. 2010;3:42–46. - PubMed
    1. Calabretta B, Perrotti D. The biology of CML blast crisis. Blood. 2004;103:4010–4022. - PubMed
    1. Luatti S, Castagnetti F, Marzocchi G, et al. Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis. Blood. 2012;120:761–767. - PubMed